Solid medium and methods for processing a sample of genetic...

Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C424S484000, C424S486000, C424S488000, C424S489000, C424S490000

Reexamination Certificate

active

06322983

ABSTRACT:

This invention relates to a solid medium for use in the storage of DNA, particularly DNA in blood samples, and to methods which comprise the use of this solid medium. In particular, the invention relates to a method for storage and transport of DNA on the solid medium, as well as to methods which involve either (a) the recovery of the DNA from the solid medium or (b) the use of the DNA in situ on the solid medium (for example, DNA sequence amplification by the polymerase chain reaction).
BACKGROUND OF THE INVENTION
The DNA in blood samples (hereinafter referred to as “blood DNA”) is used for the purposes of diagnosis of genetic diseases, diagnosis and monitoring of blood-borne parasitic diseases such as malaria, the determination of paternity, and the monitoring of other unusual cell populations in the blood as can occur in some neoplasias. For these purposes, the term “blood DNA” is used to cover all sources of DNA commonly found in blood, and thus includes the DNA of the human patient from whom the blood sample was obtained, as well as the DNA in any other organisms circulating within his/her blood.
It is a principal object of the present invention to provide a solid medium and method whereby DNA, particularly DNA in blood samples, may be conveniently and reliably stored, and if desired transported (for example from a hospital or doctor's surgery to a pathology laboratory), in a form suitable for either the recovery of the DNA for analysis or the use of the DNA in situ on the solid medium.
In the past, blood DNA has been transported as purified DNA, liquid blood, frozen blood or blood dried onto paper, however, all these methods have disadvantages. Transport of blood DNA as dried, purified DNA is most desirable, but it requires a high standard of technical assistance to be available at the places of collection. Thus, since such technical assistance is usually not available at the collection places, whole blood or other crude samples are usually sent to a central facility where the DNA is purified. Transport of liquid blood involves the need for sterility of collection and this is extremely inconvenient under some circumstances, e.g. where the sample is a heel-prick taken from an infant. The transport of liquid blood or frozen blood also demands temperature control and an appropriate transport system other than the regular postal system. This is true even before the question of hygiene is considered. In addition, the modern problems with pathogens such as the “AIDS” virus completely rule out the transport of any potentially infective liquid or frozen sample except under proper and expensive supervision.
Blood dried onto filter paper is a proven alternative to the above procedures and it has been shown that DNA can be extracted and isolated from dried whole blood spots in a form and in sufficient quantities for use in DNA analysis
1
. This procedure still suffers from a number of disadvantages. Thus, there has been no deliberate and rapid destruction of most pathogens, and there has been no deliberate inhibition of the processes degrading the DNA other than that caused by desiccation. Slow desiccation or even a small degree of rehydration under conditions of high relative humidity will allow the growth of DNA-destroying microflora. Even in the presence of bacteriostatic agents of the type that do not denature proteins, there will be conditions that permit enzymic-autolytic breakdown of the DNA and some nonenzymic breakdown of the DNA (in enzymic-autolytic breakdown, dying or damaged tissues, either human cells or parasite cells, activate enzymes that degrade their own components). There is also considerable difficulty desorbing very high molecular weight DNA from paper, if this is required. Surface adsorption effects can cause losses of DNA and this will cause the preferential loss of the least degraded, i.e. the most desired class of DNA molecules.
SUMMARY OF THE INVENTION
According to the present invention there is provided a solid medium for storage of DNA, including blood DNA, which comprises a solid matrix having a compound or composition which protects against degradation of DNA incorporated into or absorbed on the matrix.
Preferably, the solid matrix comprises a solid support, for example, an absorbent cellulose-based paper (such as filter paper) or a micromesh of synthetic plastics material, with the DNA-protecting compound or composition absorbed onto the solid support. Alternatively, the solid matrix may include a suitable binder material so that the matrix is in the form of a compressed tablet or pellet, with the DNA-protecting compound or composition incorporated into or absorbed onto the tablet or pellet.


REFERENCES:
patent: Re. 35716 (1998-01-01), Stapleton et al.
patent: 3418079 (1968-12-01), Rey et al.
patent: 3616259 (1971-10-01), Beutler
patent: 4277249 (1981-07-01), Broughton
patent: 4299916 (1981-11-01), Litman et al.
patent: 4455370 (1984-06-01), Bartelsman et al.
patent: 4666837 (1987-05-01), Harford et al.
patent: 4677054 (1987-06-01), White et al.
patent: 4695548 (1987-09-01), Cantor et al.
patent: 4789630 (1988-12-01), Bloch et al.
patent: 4831125 (1989-05-01), Saltzgaber-Muller
patent: 4895795 (1990-01-01), Frazier et al.
patent: 4945052 (1990-07-01), Hardy et al.
patent: 4965190 (1990-10-01), Woo et al.
patent: 5057410 (1991-10-01), Kawasaki et al.
patent: 5089387 (1992-02-01), Tsay et al.
patent: 5092466 (1992-03-01), Anderson
patent: 5188963 (1993-02-01), Stapleton
patent: 5216132 (1993-06-01), Basi
patent: 5281516 (1994-01-01), Stapleton et al.
patent: 5346672 (1994-09-01), Stapleton et al.
patent: 5382511 (1995-01-01), Stapleton
patent: 5413924 (1995-05-01), Kosak et al.
patent: 5432097 (1995-07-01), Yourno
patent: 5436129 (1995-07-01), Stapleton
patent: 5451500 (1995-09-01), Stapleton
patent: 5496562 (1996-03-01), Burgoyne
patent: 5616478 (1997-04-01), Chetverin et al.
patent: 5756126 (1998-05-01), Burgoyne
patent: 5807527 (1998-09-01), Burgoyne
patent: 5976572 (1999-11-01), Burgoyne
patent: 5985327 (1999-11-01), Burgoyne
patent: B 30256/84 (1985-01-01), None
patent: 0 130 523 A2 (1985-01-01), None
patent: 0 221 308 A1 (1987-05-01), None
patent: 0 261 955 A2 (1988-03-01), None
patent: WO 90/03959 (1990-04-01), None
patent: WO 91/07486 (1991-05-01), None
patent: WO93/07292 (1993-04-01), None
patent: WO 93/19207 (1993-09-01), None
patent: WO 94/26935 (1994-11-01), None
patent: WO 96/11406 (1996-04-01), None
Gibco/BRL Life Technologies catalog, 1993-1994, p. R-34.*
Bruce E. Ames, et al. “Uric Acid Provides an Antioxidant Defense in Humans Against Oxidant-and Radical-Caused Aging and Cancer: A Hypothesis,”Proc. Nat.'l Acad. Sci. USA 79(11):6858-6862 (Nov. 1981).
Leigh Burgoyne Ph.D., et al., Safe Collection, Storage and Analysis of DNA From Blood, Abstract of Conference: 5thInternational Symposium on Human Identification, Oct. 8-11, 1994.
Declan Butler, UK to set up DNA database of criminals . . . ,Nature 370(6491):588-589 (Aug. 1994).
P. T. Gilham, “The Synthesis of Polynucleotide-Celluloses and Their Use in the Fractionation of Polynucleotide,:”J. American Chem. Soc. 86:4982-55 (Oct. -Dec. 1964).
Peter Gill, et al., “Forensic Application of DNA ‘Fingerprints’”,Nature 318:577-79 (1985).
M. Gross-Bellard, et al., “Isolation of High-Molecular-Weight DNA from Mammalian Cells,”Eur. J. Biochem. 36: 32-38 (Jul. 2, 1973).
Michael A. Harvey, et al., “Impregnated 903 Blood Collection Paper: A Tool for DNA Preparation From Dried Blood Spots for PCR Application”. (Date not available).
Innis et al., “RNA Processing: APO-B,” by Lyn M. Powell,PCR ProtcolsChapter 29, pp. 237-244 (1990).
L. Jervis et al., “Purification of Ribonuclease T1on Porous Glass Affinity Adsorbents”,J. of Chromatography 97(1):33-38 (Oct. 1974).
Kwok-Wai Lam, et al., “Inhibition of Ascorbate Oxidation by Urate”,J. Inorganic Biochemistry, 22(4):241-248 (1984).
Linda Madisen, et al., “DNA Banking: The Effects of Storage of Blood Isolated DNA on the Integrity of DNA”,American J. of Med. Gen. 27(2):379-390 (1987).
T. Maniatis, et al., “Molecular Cloning—A Laboratory Manual”Cold Spri

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Solid medium and methods for processing a sample of genetic... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Solid medium and methods for processing a sample of genetic..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Solid medium and methods for processing a sample of genetic... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2602943

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.